| Adolescent fertility in low-and middle-income countries: effects and solutions AL Glassman, R Silverman, K McQueston Center for Global Development Working Paper, 2012 | 70 | 2012 |
| The efficacy of interventions to reduce adolescent childbearing in low‐and middle‐income countries: a systematic review K McQueston, R Silverman, A Glassman Studies in family planning 44 (4), 369-388, 2013 | 59 | 2013 |
| The efficacy of interventions to reduce adolescent childbearing in low‐and middle‐income countries: a systematic review K McQueston, R Silverman, A Glassman Studies in family planning 44 (4), 369-388, 2013 | 59 | 2013 |
| Performance-based financing at the Global Fund to Fight AIDS, Tuberculosis and Malaria: an analysis of grant ratings and funding, 2003–12 VY Fan, D Duran, R Silverman, A Glassman The Lancet Global Health 1 (3), e161-e168, 2013 | 40 | 2013 |
| Tackling the triple transition in global health procurement R Silverman, JM Keller, A Glassman, K Chalkidou Center for Global Development, 2019 | 36 | 2019 |
| Planning for school reopening and recovery after COVID-19 S Carvalho, J Rossiter, N Angrist, S Hares, R Silverman Center for Global Development 26, 2020 | 29 | 2020 |
| Modernising vital registration systems: why now? N Oomman, G Mehl, M Berg, R Silverman Lancet (London, England) 381 (9875), 1336-1337, 2013 | 26 | 2013 |
| En passant synaptic varicosities form directly from growth cones by transient cessation of growth cone advance but not of actin‐based motility Y Hatada, F Wu, R Silverman, S Schacher, DJ Goldberg Journal of neurobiology 41 (2), 242-251, 1999 | 24 | 1999 |
| More health for the money: putting incentives to work for the Global Fund and its partners A Glassman, V Fan, M Over, R Silverman, K McQueston, D Duran Center for Global Development, 2013 | 23 | 2013 |
| Projected health financing transitions: timeline and magnitude R Silverman Center for Global Development Working Paper, 2018 | 22 | 2018 |
| The financial flows of PEPFAR: A profile V Fan, R Silverman, D Duran, A Glassman Center for Global Development Policy Paper 27, 2013 | 17 | 2013 |
| How to get cost-effectiveness analysis right? The case of vaccine economics in Latin America A Glassman, O Cañón, R Silverman Value in Health 19 (8), 913-920, 2016 | 13 | 2016 |
| More health for the money: A practical agenda for the Global Fund and its partners A Glassman, V Fan, M Over, R Silverman, K McQueston, D Duran A report of the Center for Global Development Working Group on Value for …, 2013 | 12 | 2013 |
| Value-based tiered pricing for universal health coverage: an idea worth revisiting K Chalkidou, K Claxton, R Silverman, P Yadav Gates open research 4, 2020 | 10 | 2020 |
| How a new funding model will shift allocations from the Global Fund to Fight AIDS, tuberculosis, and malaria VY Fan, A Glassman, RL Silverman Health Affairs 33 (12), 2238-2246, 2014 | 10 | 2014 |
| When should schools reopen L Crawfurd, S Hares, J Sandefur, R Silverman Center for Global Development blog. April 23, 2020 | 8 | 2020 |
| On results reporting and evidentiary standards: spotlight on the Global Fund R Friebel, R Silverman, A Glassman, K Chalkidou The Lancet 393 (10184), 2006-2008, 2019 | 8 | 2019 |
| HIV/AIDs intervention packages in five countries: a review of budget data V Fan, D Duran, R Silverman, A Glassman Center for Global Development Policy Paper 33, 2013 | 7 | 2013 |
| How should the world pay for a coronavirus disease (COVID-19) vaccine? A Towse, K Chalkidou, I Firth, H Kettler, R Silverman Value in Health 24 (5), 625-631, 2021 | 6 | 2021 |
| Aligning incentives, accelerating impact: Next generation financing models for global health R Silverman, M Over, S Bauhoff A Report for the Center for Global Development Working Group on Next …, 2015 | 6 | 2015 |
